Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Trademark Search
BIOCRYST PHARMACEUTICALS, INC.
REGISTERED
on 04 Jul 2019
Last Applicant/ Owned by
BIOCRYST PHARMACEUTICALS INC.
2190 Parkway Lake DriveBirmingham, AL 35244
US
Serial Number
1801455 filed on 21st Sep 2016
Registration Number
TMA1036381 registered on 04th Jul 2019
Registration expiry Date
04th Jul 2029Correspondent Address
550 Burrard Street, Suite 1900Vancouver
BRITISH COLUMBIA
CA
V6C3A8
BIOCRYST PHARMACEUTICALS, INC.
Trademark usage description
pharmaceuticals for the treatment of autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of inflammatory bowel dis Read MoreClassification Information
Class [005]
Pharmaceuticals for the treatment of autoimmune and cardiovascular diseases and disorders; pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of obesity; pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; pharmaceuticals for the treatment of transplant rejection; anti-infective pharmaceuticals; anti-viral pharmaceuticals; anti-inflammatory pharmaceuticals; pharmaceuticals for the treatment of cancer including cancers of the immune system such as T-cell and B-cell leukemias and lymphomas
Classification kind code
10
Class [042]
Pharmaceutical research and drug development; medical and scientific research, namely conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; development of pharmaceuticals for the treatment of development of obesity; development of pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; development of pharmaceuticals for the treatment of transplant rejection; development of pharmaceuticals for the treatment of cancer including cancers of the immune system such as T-cell and B-cell leukemias and lymphoma
Classification kind code
10
Mark Details
Serial Number
1801455
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 55 on 04th Jul 2019 | Registered |
| Submitted for opposition 50 on 20th Oct 2017 | Allowed |
| Submitted for opposition 51 on 20th Oct 2017 | Allowance Notice Sent |
| Submitted for opposition 42 on 05th Jul 2017 | Advertised |
| Submitted for opposition 26 on 15th Jun 2017 | Approved |
| Submitted for opposition 22 on 25th Apr 2017 | Search Recorded |
| Submitted for opposition 27 on 25th Apr 2017 | Approval Notice Sent |
| Submitted for opposition 31 on 27th Sep 2016 | Formalized |
| Submitted for opposition 1 on 22nd Sep 2016 | Created |
| Submitted for opposition 30 on 21st Sep 2016 | Filed |